The antihistamine Dimebon is a drug being studied in the United States and Russia as a potential treatment for Alzheimer's disease and Huntington's disease.Medivation: Dimebon

In Russia, Dimebon became on obsolete drug of choice for allergies, but gained attention in 2000, when animal studies showed the possibility that it could treat Alzheimer's disease.The New York Times: Antihistamine Shows Promise in Treating Alzheimer’s (June 11, 2007)

In human clinical trials, Dimebon is showing to improve symptoms in neurodegenerative diseases in comparison to a placebo. In regards to Alzheimer's disease, Dimebon shows to help with cognitive function in mild to moderate cases. However, more research is vital for a better understanding of the drug's role in treating such diseases.Datamonitor: Medivation: Dimebon ever closer to Alzheimer's market (March 14, 2008)

1. Neurodegenerative Disease
2. Alzheimer's Disease
3. Huntington's Disease

The content on this page is not a substitute for professional medical advice. Please contact your physician for information on Dimebon.

• The Chem Blog: Dimebon can cure Great Grandma! (June 11, 2007)